Literature DB >> 2902892

Peripheral sympatho-inhibitory cardiovascular effects of opioid peptides in anaesthetized rabbits.

B Szabo1, L Hedler, C Schurr, K Starke.   

Abstract

1. Opioid agonists influence isolated cardiovascular tissues from rabbits, as well as the cardiovascular system of pithed rabbits, through presynaptic receptors on postganglionic sympathetic nerve fibres. The present experiments were carried out in order to study effects which result from activation of these receptors in anaesthetized rabbits. 2. In pithed rabbits with electrically stimulated sympathetic outflow, infusion of [D-Ala2-D-Leu5]-enkephalin (DADLE) 10 micrograms kg-1 min-1 and dynorphin-(1-13) (dynorphin) 1 microgram kg-1 min-1 decreased the plasma noradrenaline concentration, mean arterial pressure (MAP) and heart rate. The effects of dynorphin and, less completely, those of DADLE were antagonized by the peripherally selective opioid antagonists N-methyl naloxone bromide (NMN) 1.3 mg kg-1 and N-methyl levallorphan methanesulphonate (NML) 1-3 mg kg-1. 3. In pentobarbitone-anaesthetized rabbits, DADLE 3-30 micrograms kg-1 min-1 and dynorphin 0.3-3 micrograms kg-1 min-1 decreased the plasma noradrenaline concentration and MAP. The highest dose of dynorphin also decreased heart rate, whereas DADLE 10 micrograms kg-1 min-1 caused slight cardioacceleration. The effects of DADLE but not those of dynorphin decreased upon repeated administration. 4. The effects of dynorphin 10 micrograms kg-1 min-1 were abolished or greatly attenuated by NMN 1.3 mg kg-1 and NML 3 mg kg-1. In contrast, the antagonists reduced only slightly the blood pressure-lowering effect of DADLE 10 micrograms kg-1 min-1 and did not reduce significantly the effects of DADLE on the plasma noradrenaline level and heart rate. 5. It was concluded that systemically administered dynorphin produces sympatho-inhibition and an ensuing fall in blood pressure by an action at peripheral receptors, in all probability presynaptic Kappa-receptors on postganglionic sympathetic nerve fibres. The effects of DADLE are more complex and may involve both central and peripheral components.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902892      PMCID: PMC1854018          DOI: 10.1111/j.1476-5381.1988.tb11589.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Enkephalins presynaptically inhibit cholinergic transmission in sympathetic ganglia.

Authors:  S Konishi; A Tsunoo; M Otsuka
Journal:  Nature       Date:  1979-11-29       Impact factor: 49.962

2.  Presynaptic opioid receptors in the portal vein of the rabbit.

Authors:  B Szabo; T Wichmann; K Starke
Journal:  Eur J Pharmacol       Date:  1987-07-02       Impact factor: 4.432

3.  Bremazocine causes sympatho-inhibition and hypotension in rabbits by activating peripheral kappa-receptors.

Authors:  H Ensinger; L Hedler; B Szabo; K Starke
Journal:  J Cardiovasc Pharmacol       Date:  1986 May-Jun       Impact factor: 3.105

4.  Levallorphan methyl iodide (SR 58002), a potent narcotic antagonist with peripheral selectivity superior to that of other quaternary compounds.

Authors:  M Dragonetti; A Bianchetti; R Sacilotto; A Giudice; N Ferrarese; C Cattaneo; L Manara
Journal:  Life Sci       Date:  1983       Impact factor: 5.037

5.  Modulation of peripheral adrenergic neurotransmission by methionine-enkephalin.

Authors:  R R Gaddis; W R Dixon
Journal:  J Pharmacol Exp Ther       Date:  1982-05       Impact factor: 4.030

6.  The noradrenaline rate in the anaesthetized rabbit: facilitation by adrenaline.

Authors:  H Majewski; L Hedler; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-10       Impact factor: 3.000

7.  Effects of alpha 1- and alpha 2-adrenoceptor blocking drugs on noradrenaline release rate in anesthetized rabbits.

Authors:  H Majewski; L C Rump; L Hedler; K Starke
Journal:  J Cardiovasc Pharmacol       Date:  1983 Sep-Oct       Impact factor: 3.105

8.  Quaternary opiate antagonists lower blood pressure and inhibit leucine-enkephalin responses.

Authors:  T Giles; G Sander; H Merz
Journal:  Eur J Pharmacol       Date:  1983-11-25       Impact factor: 4.432

9.  Differential cardiovascular effects of mu, delta and kappa opiate agonists at discrete hypothalamic sites in the anesthetized rat.

Authors:  G Feuerstein; A I Faden
Journal:  Life Sci       Date:  1982 Nov 15-22       Impact factor: 5.037

10.  Blood pressure and splanchnic nerve activity are reduced by a vagally mediated opioid action.

Authors:  R N Willette; A J Krieger; H N Sapru
Journal:  J Cardiovasc Pharmacol       Date:  1982 Nov-Dec       Impact factor: 3.105

View more
  2 in total

1.  Possible regulatory role of dynorphin A in the urinary bladder.

Authors:  A Berggren; A Dahlström; A Rubenson; U Sillén
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  Evidence for verapamil-induced functional inhibition of noradrenergic neurotransmission in vivo.

Authors:  S Gurtu; S Seth; A K Roychoudhary
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.